Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization.
The agonist-induced internalization of the neurotensin receptor was studied in transfected Chinese hamster ovary cells expressing either the wild-type or a truncated rat neurotensin receptor, lacking the complete intracellular COOH-terminal end. Incubation of cells expressing the wild-type neurotensin receptor in the presence of the peptide resulted in a dramatic decrease in the [3H]neurotensin binding at the cell surface. This disappearance of cell surface binding sites resulted from the internalization of the receptor after the binding of the peptide. The receptor/peptide complexes were internalized in an intracellular compartment resistant to acid washes. The truncated receptor displayed high affinity binding properties for neurotensin in cell homogenates and activated phospholipase C as did the wild-type receptor. However, in cells expressing the truncated receptor, incubation with neurotensin only induced a partial decrease in cell surface binding, and internalization of the bound peptide was also impaired. On cell homogenates, the GTP analogue Gpp(NH)p was found to decrease the affinity of [3H]neurotensin for the wild-type receptor, whereas no similar effect was observed with the truncated receptor. These results show that the intracellular COOH-terminal region of the rat neurotensin receptor is not required for its functional coupling with intracellular G protein but is involved in the shift of the affinity of the receptor for the agonist, which occurs as a consequence of receptor activation and coupling. Because the truncated receptor was shown to internalize poorly, it may be proposed that internalization is not directly related to the activation of G protein but rather is a consequence of modification of receptor affinity, after activation by the agonist.
Hermans
E
E
Laboratoire de Neurochimie, Université Catholique de Louvain, Brussels, Belgium.
Octave
J N
JN
Maloteaux
J M
JM
D000818:Animals; D001483:Base Sequence; D001667:Binding, Competitive; D016466:CHO Cells; D002462:Cell Membrane / Q000378:metabolism; D006224:Cricetinae; D017931:DNA Primers; D004789:Enzyme Activation; D019204:GTP-Binding Proteins / Q000378:metabolism*; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D007295:Inositol Phosphates / Q000378:metabolism; D007700:Kinetics; D008969:Molecular Sequence Data; D009496:Neurotensin / Q000378:metabolism / Q000494:pharmacology*; D016133:Polymerase Chain Reaction; D011720:Pyrazoles / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D051381:Rats; D018028:Receptors, Neurotensin / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism; D017384:Sequence Deletion; D014162:Transfection; D010738:Type C Phospholipases / Q000378:metabolism*
D017931:DNA Primers; D007295:Inositol Phosphates; D011720:Pyrazoles; D011804:Quinolines; D018028:Receptors, Neurotensin; D011994:Recombinant Proteins; C079087:SR 48692; D006165:Guanylyl Imidodiphosphate; D009496:Neurotensin; D010738:Type C Phospholipases; D019204:GTP-Binding Proteins